Your browser doesn't support javascript.
SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target.
Giovannoni, Federico; Quintana, Francisco J.
  • Giovannoni F; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Quintana FJ; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. fquintana@rics.bwh.harvard.edu.
Cell Res ; 31(1): 1-2, 2021 01.
Article in English | MEDLINE | ID: covidwho-1387277
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Drug Delivery Systems / Receptors, Aryl Hydrocarbon / Basic Helix-Loop-Helix Transcription Factors / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Limits: Animals / Humans Language: English Journal: Cell Res Year: 2021 Document Type: Article Affiliation country: S41422-020-00447-9

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Drug Delivery Systems / Receptors, Aryl Hydrocarbon / Basic Helix-Loop-Helix Transcription Factors / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Limits: Animals / Humans Language: English Journal: Cell Res Year: 2021 Document Type: Article Affiliation country: S41422-020-00447-9